Recent Articles

All product descriptions and articles provided on this website are intended strictly for informational and educational purposes. Our products are designed exclusively for in-vitro research (i.e., experiments conducted outside of a living organism, typically in glassware such as test tubes or petri dishes). These compounds are not approved by the FDA for use in humans or animals. They are not medications, nor are they intended to diagnose, treat, prevent, or cure any disease or medical condition. Any bodily administration-human or animal-is strictly prohibited by law. Our products are not for human consumption under any circumstances.

How Effective Is BPC-157 in Chronic Tendon Injury Recovery?

How Effective Is BPC-157 in Chronic Tendon Inju...

Preclinical studies suggest that BPC-157 [1] may significantly support chronic tendon injury healing by promoting fibroblast activity, improving collagen organization, and enhancing tendon repair. Animal studies also report better structural integrity...

Posted in: News

read more
What Do Studies Suggest About GHK-Cu’s Protective Activity in COPD and Lung Fibrosis?

What Do Studies Suggest About GHK-Cu’s Protecti...

GHK-Cu is a copper-binding peptide investigated for protective activity in COPD and lung fibrosis research. Experimental studies demonstrate regulation of inflammatory signaling, oxidative stress responses, and extracellular matrix remodeling pathways. In vitro and in vivo findings indicate reduced inflammatory injury, improved tissue repair, and controlled fibrotic signaling, providing mechanistic insight into pulmonary tissue protection and regenerative respiratory biology.

Posted in: News

read more
How Does NAD+ Dysregulation Drive the Development of Mitochondrial Disease?

How Does NAD+ Dysregulation Drive the Developme...

This mechanistic review examines how impaired NAD+ homeostasis contributes to mitochondrial disease pathogenesis. It evaluates disrupted redox signaling, abnormalities in oxidative phosphorylation, and excessive NAD+ utilization across mitochondrial dysfunction models. Furthermore, the regulatory functions of sirtuins, PARPs, and CD38 are critically assessed. Consequently, the review integrates preclinical evidence linking NAD+ depletion with mitochondrial bioenergetic instability and progressive cellular dysfunction.

Posted in: News

read more
Preclinical Assessment of BPC-157 and TB-500 in Rodent Tendon Repair Systems

Preclinical Assessment of BPC-157 and TB-500 in...

This research-focused article analyzes tendon repair responses to BPC-157 and TB-500 in rodent models. It examines collagen organization, fibroblast dynamics, angiogenesis, biomechanical performance, pharmacokinetics, and translational limitations. The discussion highlights gaps in long-term fibrosis evaluation and dose-response definition, emphasizing the need for structured preclinical studies to establish safety thresholds and improve tendon research reliability.

Posted in: News

read more
How Does Melanotan II Interact With Appetite Regulation Pathways?

How Does Melanotan II Interact With Appetite Re...

Melanotan II influences appetite regulation by activating melanocortin receptors involved in hunger suppression and satiety signaling. It affects neural and metabolic pathways linked to food intake, energy balance, and obesity research, helping scientists better understand appetite control, feeding behavior, and metabolic homeostasis in experimental studies.

Posted in: News

read more
Does MOTS-C Modulate AMPK Signaling During Cellular Energy Stress?

Does MOTS-C Modulate AMPK Signaling During Cell...

This research-based article explores how MOTS-C modulates AMPK activity during cellular energy stress. It covers mitochondrial-nuclear communication, AMPK phosphorylation, metabolic adaptation, and insulin sensitivity. Evidence from preclinical studies shows how MOTS-C supports energy balance, oxidative metabolism, and stress-responsive recovery while avoiding chronic metabolic overstimulation.

Posted in: News

read more